Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

IDNAvsHTECETF Comparison

ETF 1
IDNA

iShares Genomics Immunology and Healthcare ETF

This fund is part of
BioTech & Genomics
-2.11%
VS
ETF 2
HTEC

Robo Global Healthcare Technology and Innovation ETF

This fund is part of
Multiple Trends
-3.1%

iShares Genomics Immunology and Healthcare ETF (IDNA) belongs to the BioTech & Genomics segment. Robo Global Healthcare Technology and Innovation ETF (HTEC) is part of the Multiple Trends segment. IDNA's top 3 sector exposures are Healthcare and Non-Corporate. In contrast, HTEC's top sector exposures are Healthcare and Consumer Non-Cyclicals.Business Services,  IDNA is less expensive with a Total Expense Ratio (TER) of 0.47%, versus 0.8% for HTEC. IDNA is up 22.74% year-to-date (YTD) with +$29M in YTD flows. HTEC performs worse with 6.35% YTD performance, and +$18M in YTD flows. Run a side-by-side ETF comparison of IDNA and HTEC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IDNA vs HTEC performance and flow charts

Performance

024681012%Jun 23Jun 30Jul 8Jul 15Jul 22

Cumulative Flows

0 M5 M10 M15 MJun 23Jun 30Jul 8Jul 15Jul 22

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/24/2026
1M3MYTD1Y3Y5Y
Perf.
IDNA
HTEC
+1.04%+7.10%
+7.23%+12.77%
+22.74%+6.35%
+45.35%+30.45%
+40.59%+24.66%
-31.37%-18.94%
Flows
IDNA
HTEC
+$13M+$14M
+$16M+$16M
+$29M+$18M
+$25M+$17M
+$4M-$27M
+$10M-$82M
Volatility and drawdown
3M1Y3Y5Y
Volatility
IDNA
HTEC
+25.18%+22.46%
+23.90%+20.14%
+24.18%+20.60%
+28.01%+24.08%
Max drawdown
IDNA
HTEC
-8.02%-4.24%
-10.60%-16.84%
-29.33%-28.61%
-68.19%-56.05%
Max drawdown duration
IDNA
HTEC
19d17d
46d160d
347d546d
1769d1785d
Trading data

Create an account to view trading data

Join for free
IDNA
HTEC
Last sale
7/27/2026 at 1:30 PM
$32.24
$37.77
Previous close
07/24/2026
$32.03
$37.53
Consolidated volume
07/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IDNA
HTEC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/27/2026 at 1:30 PM
Live
Closed
IDNA
HTEC
Last price
$32.24
$37.77
1D performance
+0.66%
+0.64%
AuM$188.81 M$74.46 M
E/R0.47%0.8%
Characteristics
IDNA
HTEC
Management strategyPassivePassive
ProvideriSharesROBO Global ETFs
BenchmarkNYSE FactSet Global Genomics and Immuno Biopharma IndexROBO Global Healthcare Technology and Innovation
N° of holdings4863
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 11, 2019June 25, 2019
ESGNoYes
Advertisement
Exposure

Countries

IDNA
USA
61.08%
Germany
8.29%
France
7.46%
Other
23.17%
HTEC
USA
75.6%
Other
24.4%

Sectors

IDNA
Healthcare
99.73%
Other
0.27%
HTEC
Healthcare
94.52%
Other
5.48%
Advertisement

Diversification

IDNA

Total weight of top 15 holdings out of 15

59.79%
HTEC

Total weight of top 15 holdings out of 15

30.96%

Top 15 holdings

Data as of June 30, 2026
IDNA
Twist Bioscience Corp.
5.18%
Moderna, Inc.
5.14%
Bayer AG
4.61%
Revolution Medicines, Inc.
4.37%
Genmab A/S
3.88%
Vertex Pharmaceuticals, Inc.
3.87%
Incyte Corp.
3.86%
Merck & Co., Inc.
3.71%
Ipsen SA
3.69%
BioNTech SE
3.68%
ImmunityBio, Inc.
3.60%
Exelixis, Inc.
3.60%
Takeda Pharmaceutical Co., Ltd.
3.59%
GSK Plc
3.53%
Roche Holding AG
3.49%
HTEC
Twist Bioscience Corp.
2.58%
Natera, Inc.
2.33%
Tempus AI, Inc.
2.21%
Guardant Health, Inc.
2.20%
Adaptive Biotechnologies Corp.
2.06%
Arrowhead Pharmaceuticals, Inc.
2.06%
Vertex Pharmaceuticals, Inc.
2.05%
Medpace Holdings, Inc.
2.00%
Axogen, Inc.
1.99%
LivaNova Plc
1.97%
Thermo Fisher Scientific, Inc.
1.96%
Moderna, Inc.
1.95%
Stryker Corp.
1.90%
Lonza Group AG
1.86%
Illumina, Inc.
1.84%
Frequently asked questions about IDNA and HTEC

How have the IDNA and HTEC ETFs performed in 2026?

As of July 24, 2026, IDNA is up 22.74% year-to-date (YTD), while HTEC has returned 6.35%. That puts IDNA better performer ahead so far this year.

Which ETF is attracting more investor money: IDNA or HTEC?

Year-to-date, the IDNA ETF saw +$29M in flows, compared to +$18M for HTEC.

Which ETF is more volatile: IDNA or HTEC?

Over the past year, IDNA had a volatility of 23.9%, while HTEC experienced 20.14%.

Which ETF is bigger: IDNA or HTEC?

As of July 24, 2026, IDNA holds $188.81 M in assets under management (AUM), while HTEC manages $74.46 M.

What sectors do the IDNA and HTEC ETFs invest in?

IDNA leans toward sectors like Healthcare. Meanwhile, HTEC focuses on Healthcare.

What are the top holdings of the IDNA ETF and HTEC ETF?

IDNA top holdings include Twist Bioscience Corp., Moderna, Inc. and Bayer AG. HTEC holds in its top three: Twist Bioscience Corp., Natera, Inc. and Tempus AI, Inc..

Which ETF is more diversified: IDNA or HTEC?

IDNA holds 48 securities with 59.79% of its assets in the top 15. HTEC has 63 securities and a top 15 weight of 30.96%.

Advertisement
Latest news about IDNA & HTEC
Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026